Previous Chapter Chapter 25: Antitumor Biologies: Strategies for Success in an Expanding Market Next Chapter

By: Decision Resources Inc

In: The SAGE Handbook of Healthcare

Chapter 25: Antitumor Biologies: Strategies for Success in an Expanding Market

  • Citations
  • Add to My List
  • Text Size

Antitumor Biologies: Strategies for Success in an Expanding Market
Antitumor biologies: Strategies for success in an expanding market
Introduction

The development of biological products, specifically protein drugs, has been a cornerstone of the biotechnology industry, and it has played a key role in the advancement of cancer treatments over the past 15 years. Biotechnology researchers and companies have used major protein drug technologies – namely, recombinant DNA and monoclonal antibody (MAb) technologies – to design and produce protein drugs directed against cancer. Development of anticancer biological agents has spanned more than three decades, from the overblown excitement over interferons as cancer treatments in the late 1970s and early 1980s (which proved to be largely unfounded) to the marketed drugs of the 1990s and early 21st century. The ...

Looks like you do not have access to this content.

Login

Don’t know how to login?

Click here for free trial login.

Back to Top

Copy and paste the following HTML into your website